| COVID-19 |
1 |
1 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.69 |
| COVID-19 Vaccine |
0 |
0.59 |
| Severe Acute Respiratory Syndrome |
0 |
0.56 |
| Body Mass Index |
0 |
0.42 |
| Preventive Screening |
0 |
0.42 |
| Board Certification |
0 |
0.28 |
| Renal Disease |
0 |
0.2 |
| Acute Respiratory Distress Syndrome |
0 |
0.16 |
| Type 2 Diabetes Mellitus |
0 |
0.16 |
| Cardiovascular disease |
0 |
0.14 |
| Chronic Disease |
0 |
0.14 |
| Clinical Guidelines |
0 |
0.14 |
| COVID-19 and Diabetes |
0 |
0.14 |
| Diabetes Research |
0 |
0.14 |
| Endocrinology |
0 |
0.14 |
| Fatigue |
0 |
0.14 |
| ICD-9 and ICD-10 |
0 |
0.14 |
| Kidney |
0 |
0.14 |
| Metabolism |
0 |
0.14 |
| Noncommunicable Diseases |
0 |
0.14 |
| Pain |
0 |
0.14 |
| Pandemic |
0 |
0.14 |
| Prediabetes |
0 |
0.14 |
| Primary Care |
0 |
0.14 |
| Washington |
0 |
0.14 |
| Metabolic Syndrome |
0 |
0.06 |
| Type 1 Diabetes Mellitus |
0 |
0.06 |
| Cardiovascular Risk Management |
0 |
0.04 |
| Electronic Health Record (EHR) |
0 |
0.04 |
| Obesity |
0 |
0.04 |
| Pain Management |
0 |
0.04 |
| Vaccines |
0 |
0.04 |